Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome

NCT03908970 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

364

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: 1% OPA-15406
DRUG: Placebos

Sponsor

Otsuka Pharmaceutical Co., Ltd.